The independent source for health policy research, polling, and news.
1,601 - 1,620 of 1,670 Results
Drugmakers have brought almost 450 orphan drugs to market and collected rich incentives but nearly a third of those products aren’t new or were repurposed multiple times, an investigation shows.
States that expanded eligibility for Medicaid have failed to enroll large numbers of a significant group that stood to benefit: ex-inmates.
Drug prices rise for a variety of reasons but opportunities for the government to control them is limited.
Policyholders reason that their health is good — for now — and they don’t see the need for costly comprehensive coverage. Detractors say the plans undermine the Affordable Care Act, and agents advise reading the fine print. “You basically have to be in perfect health,” says one.
As governor of Indiana, Mike Pence expanded Medicaid with conservative tweaks, responded to an HIV outbreak with a limited needle-exchange program and signed one of the most restrictive abortion laws in the country.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about the latest Trump administration efforts to address high drug prices, what’s next for short-term health insurance plans and insider trading charges against a New York GOP congressman.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Julie Appleby of Kaiser Health News discuss the health politics of the latest Supreme Court pick, as well as the Trump administration’s efforts to further undermine the Affordable Care Act. Plus, for extra credit, the panelists recommend their favorite health stories of the week.
Senate Democrats see health care as an issue that could keep their caucus unified as the confirmation battle heats up.
Despite a decision by the Trump administration to ask a court to nullify the portion of the health law guaranteeing coverage to the sick, the Kaiser Family Foundation poll finds most people want insurers to be required to offer coverage and not charge more.
Oral arguments are heard in a legal challenge regarding the state of Kentucky’s requirement that adults who gained Medicaid coverage under the Affordable Care Act’s expansion prove that they work or volunteer in order to get health coverage.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trump’s proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.
Post-9/11, Giuliani Partners helped craft a plan that put a halt to a probe into Purdue’s marketing of OxyContin.
Patrick Kennedy, a former congressman from Rhode Island, and Newt Gingrich, who was once the House speaker, are advancing policies to combat this national crisis.
Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Talking Points Memo discuss the latest on states’ efforts to reshape their Medicaid programs, the kerfuffle over President Donald Trump’s medical records and comments by former Health and Human Services Secretary Tom Price about Congress’ repeal of the Affordable Care Act’s “individual mandate” penalty. Rovner also interviews Harvard professor Robert Blendon about the complex politics of health in the coming midterm elections.
A double-digit increase, which follows two years of moderate rate hikes, is likely to resonate across the country in debate over Obamacare.
It was a big win for pro-abortion rights advocates, but abortion opponents are not daunted. Stay tuned for how it will affect presidential politics and the next generation of women voters.
The Trump administration is shaming brand-name drugmakers who refuse to sell samples so generics can be made from their products.
Health insurers’ initial premium requests indicate stiff price hikes for consumers, just as bipartisan talks in Congress fall flat.
In California, backers of a plan to allow adults living in the country illegally to buy coverage on the state’s exchange hurry to get federal approval — fearing opposition or inaction under a new administration.
Just weeks before midterm elections, a move by federal health officials spotlights a contentious issue: the use of human fetal tissue in research. Here’s what you need to know to understand the debate.
© 2026 KFF